ID
41471
Beschreibung
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. In this form (Status, Adverse Events Status) the occurrence of adverse events and the status of COPD is to be documented during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Stichworte
Versionen (1)
- 21.10.20 21.10.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
21. Oktober 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Status, Adverse Events Status
- StudyEvent: ODM
Beschreibung
Status
Alias
- UMLS CUI-1
- C0449438
Beschreibung
COPD medication during study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0024117
- UMLS CUI [1,2]
- C0013227
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C0347984
Beschreibung
Concomitant medications during study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beschreibung
COPD exacerbation during study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0740304
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beschreibung
Lower respiratory tract infection requiring antibiotics treatment
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0149725
- UMLS CUI [1,2]
- C1514873
- UMLS CUI [1,3]
- C0003232
- UMLS CUI [1,4]
- C0008976
- UMLS CUI [1,5]
- C0347984
Beschreibung
AE Status
Alias
- UMLS CUI-1
- C0877248
Beschreibung
Non-serious adverse events during study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beschreibung
Serious adverse event during study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Ähnliche Modelle
Status, Adverse Events Status
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0003232 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0347984 (UMLS CUI [1,5])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])